American Journal of Epidemiology Advance Access published May 17, 2006

Size: px
Start display at page:

Download "American Journal of Epidemiology Advance Access published May 17, 2006"

Transcription

1 American Journal of Epidemiology Advance Access published May 17, 2006 American Journal of Epidemiology Copyright ª 2006 by the Johns Hopkins Bloomberg School of Public Health All rights reserved; printed in U.S.A. DOI: /aje/kwj168 Practice of Epidemiology Prognostic Value of a Novel Classification Scheme for Heart Failure: The Minnesota Heart Failure Criteria Joseph Kim 1,2, David R. Jacobs, Jr. 2,3, Russell V. Luepker 2, Eyal Shahar 2, Karen L. Margolis 4, and Mark P. Becker 5 1 Medical Statistics Unit, London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom. 2 Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN. 3 Department of Nutrition, Faculty of Medicine, University of Oslo, Oslo, Norway. 4 Berman Center for Outcomes and Clinical Research, Minneapolis, MN. 5 Office of the Provost, University of South Carolina, Columbia, SC. Received for publication August 11, 2004; accepted for publication January 25, The authors present the Minnesota Heart Failure Criteria (MHFC), derived using latent class analysis from widely available items in the Framingham Criteria. The authors used 1995 and 2000 data on hospitalized Minnesota Heart Survey subjects discharged after myocardial infarction or heart failure (N ¼ 7,379). Selected Framingham Criteria variables (dyspnea, pulmonary rales, cardiomegaly, interstitial or pulmonary edema on chest radiograph, S 3 heart sound, tachycardia) plus left ventricular ejection fraction were used. The discriminatory power of the MHFC was evaluated using age- and sex-adjusted 2-year mortality. A five-class latent class analysis model was collapsed into cases and noncases. Mortality estimates discriminated noncases (18%) from cases (43%) (p < 0.001). The MHFC performed better than previous truncated criteria (Framingham Criteria: 26% noncases, 43% cases; Duke Criteria: 29%, 40%; Killip Score: 31%, 44%; Boston Score: 28%, 45%). In a subset of patients admitted for heart failure (n ¼ 5,128), the MHFC identified all but 2% (116/4,746) of cases found with a nearly full version of the Framingham Criteria. In terms of prognostic value, the MHFC are as precise as or more precise than several previous sets of truncated criteria. They closely approximate a nearly full version of the Framingham Criteria but require many fewer variables and can facilitate epidemiologic case-finding for heart failure. cardiovascular diseases; classification; diagnosis; heart diseases; heart failure, congestive; validation studies [publication type] Abbreviations: ICD-9, International Classification of Diseases, Ninth Revision; LCA, latent class analysis; LVEF, left ventricular ejection fraction; MHSAMI, Minnesota Heart Survey Acute Myocardial Infarction; MHSCHF, Minnesota Heart Survey Community Surveillance of Heart Failure. Heart failure is a major public health problem affecting over five million persons in the United States and over 23 million worldwide (1). The epidemiologic study of heart failure, however, has been partly impeded by the absence of a universally agreed-upon case definition (2 12). Though numerous case definitions have been introduced into the literature primarily in the form of epidemiologic classification schemes (13 19) most, if not all, of these criteria are based solely on a composite of signs and symptoms and ignore left ventricular ejection fraction (LVEF), a key index of underlying cardiac physiology for which there was limited data availability when the criteria were being developed (3, 5, 8, 20). In addition, existing criteria were evaluated using standard measures of validity (e.g., sensitivity and Correspondence to Dr. Joseph Kim, Medical Statistics Unit, Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom ( joseph.kim@lshtm.ac.uk). 1

2 2 Kim et al. specificity), all of which assume a perfect reference standard; given the absence of a diagnostic gold standard for heart failure, there is considerable uncertainty in the estimates of validity obtained for these criteria. In their original conception, the Framingham Criteria arguably the most widely used epidemiologic criteria for heart failure were defined by combining 17 major or minor heart-failure-related variables to form a diagnosis of heart failure in dichotomous categories (heart failure/no heart failure) (21). However, in practice, the Framingham Criteria are often implemented using only a subset of these variables, since data on many of the characteristics (e.g., circulation time) are no longer collected in routine clinical practice. It would therefore be of interest to evaluate the validity of a more abridged form of the criteria and compare this result with that of the original Framingham Criteria. Moreover, the incorporation of data on LVEF could enhance the classification process. We present a novel epidemiologic classification scheme for heart failure the Minnesota Heart Failure Criteria derived from widely available items used in the Framingham Criteria, employing latent class analysis (LCA), a probabilistic approach to disease classification which allows for and can potentially identify more precise categories of disease conditions. Validation of the Minnesota Heart Failure Criteria was performed under the assumption that persons with true cases of heart failure will have a higher risk of mortality than noncases in the 2 years following hospitalization. MATERIALS AND METHODS Study population The study included a population-based sample of patients whose records were abstracted as part of the Minnesota Heart Survey for the hospitalization discharge years 1995 and Patients were selected from two independent components of the Minnesota Heart Survey: the Acute Myocardial Infarction Study (22) and the Community Surveillance of Congestive Heart Failure Study (23). Acute myocardial infarction study. Patients selected for the Minnesota Heart Survey Acute Myocardial Infarction (MHSAMI) Study for the 1995 hospital discharge year were considered (22). Participants were residents of the Minneapolis-St. Paul, Minnesota, metropolitan area during 1995 and were between the ages of 30 and 74 years. Patients were hospitalized with an eligible International Classification of Diseases, Ninth Revision (ICD-9), discharge code for acute myocardial infarction (i.e., ICD-9 codes 410 and 411) in any of the participating regional acute-care hospitals. Trained nurses abstracted data on a 40 percent sample of men and an 80 percent sample of women. Relevant data on signs and symptoms, medical history, cardiac enzyme levels, clinical complications, therapy, and autopsy results were gathered. Congestive heart failure study. All patients in the Minnesota Heart Survey Congestive Heart Failure (MHSCHF) Study had an eligible ICD-9 discharge code for heart failure (i.e., ICD-9 code 428 or another heart-failure-related discharge code) during 1995 or 2000 (23). Consistent with the MHSAMI, patients were residents of the Minneapolis- St. Paul metropolitan area at the time of the index hospitalization, but in MHSCHF they were between the ages of 35 and 84 years. Trained nurses abstracted data from 50 percent of all hospital discharges and gathered data on patient demographic factors, medical history, physical examination, electrocardiographic findings, chest radiography, and blood laboratory results and, where available, basic information on cardiac imaging (including current and historical LVEF) and cardiac catheterization. Combined data set. A combined data set was formed on the basis of MHSCHF data for 1995 and 2000 and MHSAMI data for The data were merged to broaden the spectrum of disease (with regard to both disease severity and type of heart failure) and to enhance the generalizability of the criteria. We hypothesized that the majority of noncases would arise from MHSAMI while the majority of cases would arise from MHSCHF. Statistical methods Development of the Minnesota Heart Failure Criteria. There are numerous methods by which a classification scheme for heart failure can be derived (13, 24). For this study, we chose LCA, an established method of categorical data analysis which has been used previously to validate diagnostic tests in the absence of a perfect reference standard (25 29). LCA is ideally suited for this purpose, because it makes no assumption about the independence of errors between the diagnostic test and the reference standard, which helps in avoiding the known problem of inflated validity estimates with the use of an imperfect reference standard (29, 30). LCA uses a nonlinear statistical model to classify groups of subjects who have shared characteristics into latent classes (e.g., diagnostic subgroups) (30, 31). It achieves this by maximizing a mathematical likelihood function based on the patients distributional pattern of signs, symptoms, and physiologic markers present at the time of evaluation. Given that the distribution of criterion variables is biologically relevant to the disease classification and there are sufficiently large numbers of cases and noncases to support these categorizations, LCA can identify the disease subcategories reliably. LCA is discussed further in other publications (28, 30 32) and in Web appendix 1, which is posted on the Journal s website ( Variable selection. The variables defining the categories of heart failure were chosen on the basis of clinical relevance using the short Framingham Criteria, plus LVEF (table 1). They included dyspnea at rest or upon exertion, pulmonary rales, cardiomegaly, interstitial or pulmonary edema, the S 3 heart sound, tachycardia (resting heart rate >120 beats/minute), and LVEF (<40 percent, 40 percent, or missing data). LCA model selection. A challenge of LCA is to choose the most appropriate number of latent classes using a parsimonious set of criterion variables. We set out to identify a plausible classification structure for heart failure with the fewest possible number of criterion variables. However, given the limited availability of variables in MHSAMI, we

3 Prognostic Value of the Minnesota Heart Failure Criteria 3 TABLE 1. Sets of heart failure signs and symptoms compared with those of the Minnesota Heart Survey, 1995 and 2000 Heart failure sign or symptom Framingham Criteria (46) Existing criteria Duke Criteria (34) Killip Score (47) Boston Score (19) Minnesota Heart Survey data sets MHSCHF* Study (n ¼ 5,128) MHSAMI* Study (n ¼ 2,251) Combined data sety (N ¼ 7,379) Dyspnea z z z Pulmonary rales Cardiomegaly { Acute pulmonary edema # ** ** S 3 heart sound Tachycardia (120 beats/minute) yy Left ventricular ejection fraction percentage Paroxysmal nocturnal dyspnea Orthopnea Neck vein distension Hepatojugular reflux Weight loss Ankle edema Hepatomegaly Pleural effusion Hypotension (systolic blood pressure <90 mmhg) Night cough Vital capacity (1/3 of maximum) Increased venous pressure (>16 cm of water) Circulation time 25 seconds Venous hypertension Peripheral vasoconstriction Elevated jugular venous pressure Wheezing Upper zone flow * MHSCHF, Minnesota Heart Survey Community Surveillance of Heart Failure; MHSAMI, Minnesota Heart Survey Acute Myocardial Infarction. y Pooled data from the MHSCHF and MHSAMI studies. z Dyspnea at rest or upon exertion. Basilar or more than basilar rales. { Cardiomegaly on chest radiograph or cardiothoracic ratio 0.5. # Alveolar or interstitial pulmonary edema. ** Interstitial or pulmonary edema. yy Heart rate >110 beats/minute. opted to include all seven variables in the initial LCA model. We then compared the goodness of fit of this model with varying numbers of diagnostic classes. Nested models were evaluated through goodness-of-fit statistics: the Pearson chisquared (v 2 ) test, the likelihood ratio chi-squared (L 2 ) test, Akaike s information criterion, and the Bayesian information criterion. All LCA models were fitted using Latent GOLD (version 2.0; Statistical Innovations, Belmont, Massachusetts) (33). Mortality comparison: LCA model versus previous truncated criteria. In the absence of a perfect gold standard, a diagnostic test can be validated by comparing its results against a known consequence of the disease (34 37). Since a major predictable outcome of heart failure is short-term mortality (38 45), we hypothesized a priori that true heart failure cases would have a greater risk of mortality than noncases and that a positive deviation in mortality from noncases would reflect the discriminatory power of the criterion.

4 4 Kim et al. To this end, we fitted age- and sex-adjusted linear models to obtain absolute risk estimates of 2-year mortality for each LCA category. All-cause mortality, rather than heart-failure-specific mortality, was used to avoid possible misclassification resulting from death due to multisystem disease. We compared these estimates against those obtained similarly with sets of commonly used heart failure criteria (i.e., the Framingham Criteria (46), the Killip Score (47), the Duke Criteria (34), and the Boston Score (19)) which were adapted for use with data available in the Minnesota Heart Survey. The purpose here was to show the amount of additional information about the lethality of heart failure that is contained in a set of existing criteria, as a base for a similar examination of the LCA criteria. However, these results do not reflect the full potential of each criterion, since only those variables for which data are routinely collected in hospitals and are readily available in the Minnesota Heart Survey were used (referred to herein as previous truncated criteria ). In MHSCHF, it was possible to compute results for both a short set of Framingham Criteria (a six-item score based on widely available items) and a long set of Framingham Criteria (a 13-item score based on variables commonly assessed when evaluating possible heart failure) (table 1). It was only possible to compute results for the short Framingham Criteria in MHSAMI, since the collection of data on heart-failure-related variables was not part of the central aims of that study. Of the original 17 Framingham Criteria items (table 1), the long Framingham Criteria excluded factors that are not currently commonly assessed in patients being evaluated for possible heart failure: circulation time (25 seconds), increased venous pressure (>16 cm of water), vital capacity (1/3 of maximum), and night cough. To allow comparability with previous truncated criteria, LCA classes were collapsed into dichotomous disease categories (i.e., noncases and cases). We assessed possible interaction of the relation between diagnostic criteria and mortality with LVEF. All statistical analysis (excluding LCA) was performed using SAS for Windows (version 8.2; SAS Institute, Inc., Cary, North Carolina). RESULTS Development of the Minnesota Heart Failure Criteria We began by examining the prevalence of each criterion variable in all subjects, as well as in cases identified by the short Framingham Criteria separately for MHSAMI and MHSCHF (table 2). As expected, more subjects in MHSCHF than in MHSAMI presented with each of the seven heart failure criterion variables. Among cases identified by the short Framingham Criteria, pulmonary rales were less common in MHSAMI as compared with MHSCHF (40 percent vs. 95 percent), as were the S 3 heart sound (9 percent vs. 22percent) and dyspnea(78 percentvs. 93percent). MHSAMI subjects who fulfilled the short Framingham Criteria for heart failure more often had a high heart rate (30 percent vs. 16 percent) and pulmonary edema (77 percent vs. 55 percent). The prevalences of cardiomegaly and low ejection fraction were similar between MHSCHF and MHSAMI. Bearing these differences in mind, we found that a fiveclass LCA model had a good fit to the observed data (Web appendix 1). The distributions of signs and symptoms by diagnostic class are shown in table 3. The LCA model shows that class 1 subjects had the lowest probability of presenting with the seven criterion variables: Few, if any, of these subjects had the S 3 heart sound, interstitial or pulmonary edema, or tachycardia, though a relatively large proportion (40 percent) of subjects had dyspnea. Therefore, on the basis of the distributional pattern of conditional probabilities for the seven criterion variables, we labeled class 1 subjects noncases. In contrast, subjects in class 5 had the largest probability of presenting with a criterion variable: Nearly all of them had dyspnea, pulmonary rales, and cardiomegaly, while they also had the highest probability of presenting with depressed LVEF. Few subjects had the S 3 heart sound in any other heart failure class, whereas over half of all class 5 subjects had the S 3 heart sound. Therefore, we labeled these subjects as having advanced heart failure. Among the remaining classes, the distinctions were less clear: A defining feature of class 3 was that nearly all subjects had interstitial or pulmonary edema, in contrast to class 2, where only 1 percent of subjects had the sign. Among class 3 subjects, the presence of interstitial or pulmonary edema was consistent with a high prevalence of dyspnea and pulmonary rales. We hypothesized that subjects in classes 2, 3, and 4 had one form or another of heart failure. The prevalence of each diagnostic class (i.e., unconditional probability) is also shown in table 3. The noncases formed a large group comprising 28 percent (2,057/7,379) of the study population; the remaining 72 percent were classified as having some form of heart failure. The distribution of conditional probabilities and the consequent formation of the diagnostic classes were consistent with the population of origin: The noncases had the largest proportion derived from MHSAMI (84 percent), whereas nearly all subjects with advanced heart failure originated from MHSCHF. The majority of subjects with an LVEF under 40 percent originated from the MHSCHF data set: Only 32 percent of subjects in class 4 and 1 percent of subjects in class 5 were from MHSAMI. The posterior probabilities of diagnostic class membership for subjects with all signs and symptoms and a known LVEF (2 7, or 128 patterns), as well as those with missing data on LVEF (2 6, or 64 possible patterns), are shown in Web appendix 2 ( One hundred and fifty of the 192 possible response patterns were observed in our study population; we observed at least 10 patients in 82 categories. The response patterns listed in Web appendix 2, together with LCA class assignment based on their respective posterior probabilities, form the Minnesota Heart Failure Criteria. Application of the Minnesota Heart Failure Criteria in an epidemiologic setting is illustrated through an example: Suppose retrospectively abstracted medical records indicate that a subject had pulmonary rales, the S 3 heart sound, interstitial or pulmonary edema, cardiomegaly, and dyspnea

5 Prognostic Value of the Minnesota Heart Failure Criteria 5 TABLE 2. Distribution of heart failure signs and symptoms at the time of the index hospitalization, by data set, Minnesota Heart Survey, 1995 and 2000 Heart failure sign/ symptom present? MHSAMIy Study (n ¼ 2,251) but had missing data for LVEF. Web appendix 2 (observation number 187) would classify this person as belonging to class 5 with 74 percent certainty. With regard to risk stratification, we can further state that the person has advanced heart failure with a 53 percent risk of 2-year mortality. A simple SAS program that provides an algorithm for classifying people into the corresponding LCA categories based on the seven manifest variables for heart failure is downloadable from a University of Minnesota website ( Mortality comparison: previous truncated criteria versus Minnesota Heart Failure Criteria All patients The results shown in tables 4 and 5, when interpreted together, establish the discriminatory power of the Minnesota Heart Failure Criteria. Table 4 presents the 2-year mortality MHSCHFy Study (n ¼ 5,128) Heart failure cases only* MHSAMI Study (n ¼ 253) MHSCHF Study (n ¼ 3,983) No. % No. % No. % No. % Dyspnea No 1, Yes 1, , , Pulmonary rales No 2, Yes , , Cardiomegaly on chest radiograph No 1, , Yes , , Interstitial or pulmonary edema No 1, , , Yes , , S 3 heart sound No 2, , , Yes Heart rate >120 beats/minute No 2, , , Yes Left ventricular ejection fraction <40% No , , Yes , , Missing data 1, , , * Based on the short Framingham Criteria (six variables for which data were available in both studies). y MHSAMI, Minnesota Heart Survey Acute Myocardial Infarction; MHSCHF, Minnesota Heart Survey Community Surveillance of Heart Failure. difference between labeled cases and noncases according to the previous truncated criteria (short Framingham Criteria: 26 percent noncases vs. 43 percent cases; Duke Criteria: 29 percent noncases vs. 40 percent cases; Killip Score: 31 percent noncases vs. 44 percent cases; Boston Score: 28 percent noncases vs. 45 percent cases). As compared with the previous truncated criteria, noncases identified by the Minnesota Heart Failure Criteria had the lowest mortality (18 percent), while cases had mortality equal to that of the short Framingham Criteria (43 percent) (p for difference < 0.001; table 5). Moreover, cases with advanced heart failure had a significantly greater risk of mortality than usual heart failure cases (47 percent vs. 42 percent; p ¼ 0.003). The difference in mortality between heart failure and advanced heart failure was greater in MHSAMI (33 percent heart failure vs. 53 percent advanced heart failure; p ¼ 0.067) than in MHSCHF (45 percent heart failure vs. 50 percent advanced heart failure; p ¼ 0.014), though the

6 6 Kim et al. TABLE 3. Marginal percentage of persons with heart failure symptoms, signs, and functional measures in each assigned latent class analysis class, ordered by the probability of occurrence in class 5, Minnesota Heart Survey, 1995 and 2000 Heart failure sign or symptom statistical significance was marginal because there were only nine cases with advanced heart failure in MHSAMI. We also found that the discriminatory power of each criterion was modified by LVEF. Among cases identified by previous truncated criteria (table 4), persons with a normal LVEF always had lower mortality than persons with a low LVEF, while those with a low LVEF and missing data had higher mortality. The lowest mortality was seen in noncases with normal LVEF (table 4); it equaled that of Minnesota Heart Failure Criteria noncases in the combined data set (table 5). In both tables, persons with missing data on LVEF always had an intermediate risk, and those noncases with a low LVEF performed as poorly as the cases. In addition, we found that the majority of persons in MHSAMI had a favorable mortality estimate (9 percent), while nearly all of the cases had an estimate comparable to that of the noncases in MHSCHF (33 percent) (table 5). Thus, the choice of using MHSAMI as the dominant source of noncases was appropriate, given that most subjects appeared to be free of heart failure and the variables required for performing LCA were easily accessible. Cross-classification of the Framingham Criteria and the Minnesota Heart Failure Criteria We found that the classification achieved using the Minnesota Heart Failure Criteria was remarkably consistent with the long Framingham Criteria, which approximate the full Framingham Criteria (seeupperhalfoftable6). In MHSCHF, the two criteria agreed in 95 percent (4,848/ 5,128) of participants, including 218 noncases and 4,630 cases. These two criteria disagreed only in 5 percent (280/ 5,128) of all cases who had an ICD-9 heart-failure-related discharge code. Among the 280 discordant pairs (116 identified by the long Framingham Criteria but missed by the TABLE 4. Absolute risk of 2-year mortality* according to previous truncated criteria for heart failure, Minnesota Heart Survey, 1995 and 2000 Classification No. of subjects Latent class analysis class Dyspnea upon rest or exertion Pulmonary rales Cardiomegaly Left ventricular ejection fraction <40% S 3 heart sound Interstitial or pulmonary edema Heart rate >120 beats/minute Prevalence of latent class No. of subjects 2,057 2,088 1, % % of subjects from the Minnesota Heart Survey Acute Myocardial Infarction Study All patients (N ¼ 7,379) 40% (n ¼ 2,203) Left ventricular ejection fraction <40% (n ¼ 2,058) Missing data (n ¼ 3,118) ARz 95% CIz AR 95% CI AR 95% CI AR 95% CI p for interactiony Short Framingham Criteria No heart failure 3, , , , , 0.29 < Heart failure 4, , , , , 0.46 Duke Criteria No heart failure 2, , , , , 0.34 < Heart failure 4, , , , , 0.41 Killip Score No heart failure 4, , , , , 0.33 < Heart failure 2, , , , , 0.48 Boston Score No heart failure 3, , , , , 0.31 < Heart failure 3, , , , , 0.49 * The combined data set (pooled data from the Minnesota Heart Survey Community Surveillance of Heart Failure (MHSCHF) Study and the Minnesota Heart Survey Acute Myocardial Infarction (MHSAMI) Study) was used in the calculation of 2-year absolute risks, adjusted for age and sex. y Missing data on left ventricular ejection fraction were excluded from statistical testing. z AR, absolute risk; CI, confidence interval. The short Framingham Criteria were based on six variables for which data were available in both the MHSCHF Study and the MHSAMI Study.

7 Prognostic Value of the Minnesota Heart Failure Criteria 7 TABLE 5. Absolute risk of 2-year mortality* according to the Minnesota Heart Failure Criteria, Minnesota Heart Survey, 1995 and 2000 Classification No. of subjects All patients (N ¼ 7,379) 40% (n ¼ 2,203) short Framingham Criteria; 164 identified only by the Minnesota Heart Failure Criteria), the proportions differently classified by the two sets of criteria and their mortality rates were similar; mortality estimates for the 280 subjects were higher than in the 218 mutually classified noncases, but not significantly so. The limitations of the short Framingham Criteria were apparent. No one was classified as a noncase by the Minnesota Heart Failure Criteria but as a case by the short Framingham Criteria. In contrast, 647 cases were missed by the Short Framingham Criteria; these cases had mortality (44 percent) equivalent to that of the 3,983 persons classified as cases by both the Minnesota Heart Failure Criteria and the long Framingham Criteria. The lower half of table 6 compares the Minnesota Heart Failure Criteria and the short Framingham Criteria in MHSAMI, where results for the long Framingham Criteria were not available. The two criteria agreed in 88 percent of participants (1,976/2,251), including 1,723 noncases and 253 cases. The cases had a 2-year risk of mortality that was equivalent to that of the MHSCHF cases identified by both the Minnesota Heart Failure Criteria and the long Framingham Criteria, while the noncases had substantially lower mortality than the noncases in MHSCHF. A total of 275 cases misclassified as noncases by the short Framingham Criteria had significantly greater mortality (32 percent) than noncases, similar to the mortality risk in MHSCHF of noncases and cases for whom the Minnesota Heart Failure Criteria and the long Framingham Criteria disagreed. DISCUSSION Left ventricular ejection fraction <40% (n ¼ 2,058) Missing data (n ¼ 3,118) ARz 95% CIz AR 95% CI AR 95% CI AR 95% CI p for interactiony Combined data set No heart failure (LCAz class 1) 2, , , , , 0.21 < Heart failure (overall) 5, , , , , 0.45 Heart failure (LCA classes 2 4) 4, , , , , 0.45 Advanced heart failure (LCA class 5) , , , , 0.58 Minnesota Heart Survey Community Surveillance of Heart Failure Study No heart failure (LCA class 1) , , , , 0.46 < Heart failure (overall) 4, , , , , 0.49 Heart failure (LCA classes 2 4) 4, , , , , 0.48 Advanced heart failure (LCA class 5) , , , , 0.62 Minnesota Heart Survey Acute Myocardial Infarction Study No heart failure (LCA class 1) 1, , , , , Heart failure (overall) , , , , 0.37 Heart failure (LCA classes 2 4) , , , , 0.38 Advanced heart failure (LCA class 5) , 0.75 { , 1.04 { * The combined data set (pooled data from the Minnesota Heart Survey Community Surveillance of Heart Failure (MHSCHF) Study and the Minnesota Heart Survey Acute Myocardial Infarction (MHSAMI) Study) was used in the calculation of 2-year absolute risks, adjusted for age and sex. y Noncases vs. cases. The distinction between heart failure and advanced heart failure was ignored. Missing data on left ventricular ejection fraction were excluded from statistical testing. z AR, absolute risk; CI, confidence interval; LCA, latent class analysis. Pooled data from the MHSCHF Study and the MHSAMI Study. { Insufficient data for calculation of parameter estimates. In this study, we set out to derive a new classification scheme for heart failure that was suitable for epidemiology specifically, one that could be useful for heart failure surveillance and mortality follow-up. We were cognizant in this endeavor that heart failure surveillance and case-finding, beyond potential cases already identified through physician diagnosis, would be unlikely to include the depth of relevant and decisive elements that the full Framingham Criteria call for. Thus, a more pragmatic classification scheme for heart failure is needed for epidemiologic research (especially if retrospective), and the LCA approach was intended to fill this gap.

8 8 Kim et al. TABLE 6. Absolute risk of 2-year mortalityy by heart failure classification in two different Minnesota Heart Survey data sets, 1995 and 2000 Latent class analysisz Heart failure present? Long Framingham Criteria Short Framingham Criteria{ (as a subset of the long Framingham Criteria) No. of subjects Mortality risk Minnesota Heart Survey Community Surveillance of Heart Failure Study (n ¼ 5,128) No No No No Yes No No Yes Yes 0 Yes No No Yes Yes No * Yes Yes Yes 3, * Minnesota Heart Survey Acute Myocardial Infarction Study (n ¼ 2,251)# No No 1, No Yes 0 Yes No * Yes Yes * * p < (compared with persons unanimously classified as noncases). y The 2-year mortality estimates shown were derived from ageand sex-adjusted linear models. z The five-class latent class analysis model was dichotomized for comparability (class 1 ¼ noncase; classes 2 5 ¼ heart failure case). The long Framingham Criteria were based on 13 variables for which data were available in the Minnesota Heart Survey Community Surveillance of Heart Failure Study. { The short Framingham Criteria were based on six variables for which data were available in both the Minnesota Heart Survey Community Surveillance of Heart Failure Study and the Minnesota Heart Survey Acute Myocardial Infarction Study. # Results for the long Framingham Criteria could not be calculated because of missing data on some variables. The Minnesota Heart Failure Criteria were derived using LCA with six widely available items from the Framingham Criteria, plus LVEF, an important marker of underlying cardiac physiology that was not included in the Framingham Criteria. The best-fitting model was a five-class model, which was collapsed into three categories of risk strata (i.e., noncase, heart failure, and advanced heart failure). Using high 2-year mortality as a proxy for true cases of heart failure which was reasonable given the high case fatality for heart failure we showed that the LCA model provides better discrimination than the short Framingham Criteria and other previous truncated criteria considered in both patients hospitalized for congestive heart failure and patients hospitalized for acute myocardial infarction. Thus, the Minnesota Heart Failure Criteria may be a suitable substitute for the long Framingham Criteria in situations that may hide heart failure, such as cases of acute myocardial infarction and chronic obstructive pulmonary disease. The fact that the long Framingham Criteria are unlikely to be implementable in such hospital records reduces their value for general heart failure surveillance. The comparability of the Minnesota Heart Failure Criteria with the long Framingham Criteria is notable, given the contrasting mechanisms by which each set of criteria was derived: The Minnesota Heart Failure Criteria are based on a statistical model and maximum likelihood estimation, whereas the Framingham Criteria are based on clinical plausibility. We caution that we were only able to evaluate the value of a scheme using limited variables originally selected for classifying myocardial infarction, because of the restricted set of signs and symptoms available in MHSAMI. Therefore, there was no control group in the MHSCHF data set; rather, we used a comparison population in whom we thought heart failure would be relatively rare. Our data cannot confirm or firmly establish how well the previous truncated criteria would have performed had we had complete information on all of the required variables. Indeed, a study would have to be specially designed to obtain such a control set; this would probably be difficult, since very few patients without suspected heart failure are tested for the full set of 17 Framingham Criteria, and several of the original signs and symptoms are now rarely clinically assessed, even in patients suspected of having heart failure. Seen in this light, MHSAMI is a rich source for comparison with the MHSCHF data set, given that several critical heart failure signs and symptoms are included in MHSAMI and that there are some bona fide heart failure cases in the MHSAMI data set. We believe that most non-heart-failure data sets (e.g., data on chronic obstructive pulmonary disease patients) will not include many of the long Framingham Criteria variables, though they are more likely to include the six Minnesota Heart Failure Criteria variables and possibly data on LVEF. In this sense the LCA method, including LVEF, is capable of doing the desired epidemiologic job namely surveillance of heart failure occurrence in a broad set of hospitalized patients, including many who were not specifically suspected of having heart failure. The generalizability of the Minnesota Heart Failure Criteria must be verified in other populations, both to check their validity in other settings and to extend them to an outpatient setting. Repeatability is of particular concern for response patterns with a small number of subjects. Another limitation of our criteria is that they did not identify a separate category corresponding to clinical isolated diastolic dysfunction. Although LVEF is related to diastolic dysfunction, the other signs and symptoms are apparently not sufficiently indicative of isolated diastolic dysfunction for the final LCA model to identify a subgroup with isolated diastolic dysfunction. Using LCA, we identified a plausible classification structure for heart failure with three categories of risk strata based on six Framingham Criteria variables for which data are readily available from medical records (i.e., dyspnea, pulmonary rales, cardiomegaly, S 3 heart sound, interstitial or pulmonary edema, and elevated heart rate), plus LVEF. We found that the LCA classification provides better discrimination between cases and noncases against several previous sets of truncated criteria and equal discrimination against a truncated form of the Framingham Criteria that closely approximates the full version but requires many

9 Prognostic Value of the Minnesota Heart Failure Criteria 9 fewer variables. The posterior probabilities from the LCA model (Web appendix 2 ( form the basis for the Minnesota Heart Failure Criteria, which have the potential to facilitate the epidemiologic classification of heart failure. ACKNOWLEDGMENTS Funding was provided in part by grants RO1-HL and RO1-HL60959 from the National Heart, Lung, and Blood Institute. The authors thank the participating hospitals in Minneapolis- St. Paul for their long-lasting support of epidemiologic research. They are indebted to the study programmers and dedicated nurse abstractors of the Minnesota Heart Survey. Conflict of interest: none declared. REFERENCES 1. Association AH. Heart and stroke statistical update. Dallas, T: American Heart Association, Purcell IF, Poole-Wilson PA. Heart failure: why and how to define it? Eur J Heart Fail 1999;1: Adams KF Jr, Zannad F. Clinical definition and epidemiology of advanced heart failure. Am Heart J 1998;135:S Banerjee P, Banerjee T, Khand A, et al. Diastolic heart failure: neglected or misdiagnosed? J Am Coll Cardiol 2002; 39: Cheng TO. Definition of heart failure. (Letter). Eur J Heart Fail 1999;1: Denolin H, Kuhn H, Krayenbuehl HP, et al. The definition of heart failure. Eur Heart J 1983;4: Harley A. The management of heart failure: a matter of definition? Cardiovasc Drugs Ther 1993;7: Tavazzi L. Towards a more precise definition of heart failure aetiology. Eur Heart J 2001;22: Wagner S, Cohn K. Heart failure. A proposed definition and classification. Arch Intern Med 1977;137: Wilhelmsen L, Eriksson H, Svardsudd K, et al. Improving the detection and diagnosis of congestive heart failure. Eur Heart J 1989;10: Yip G, Wang M, Zhang Y, et al. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 2002;87: Young JB, Pratt CM. Hemodynamic and hormonal alterations in patients with heart failure: toward a contemporary definition of heart failure. Semin Nephrol 1994;14: Mosterd A, Deckers JW, Hoes AW, et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 1997;13: Eriksson H, Caidahl K, Larsson B, et al. Cardiac and pulmonary causes of dyspnoea validation of a scoring test for clinical-epidemiological use: The Study of Men Born in Eur Heart J 1987;8: McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: The Framingham Study. N Engl J Med 1971;285: Walma EP, Hoes AW, Prins A, et al. Withdrawing long-term diuretic therapy in the elderly: a study in general practice in the Netherlands. Fam Med 1993;25: Schocken DD, Arrieta MI, Leaverton PE, et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20: Gheorghiade M, Beller GA. Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm. Am J Cardiol 1983;51: Carlson KJ, Lee DC, Goroll AH, et al. An analysis of physicians reasons for prescribing long-term digitalis therapy in outpatients. J Chronic Dis 1985;38: Jaski BE. Basics of heart failure. Boston, MA: Kluwer Academic Publishers, McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: The Framingham Study. N Engl J Med 1971;285: McGovern PG, Jacobs DR Jr, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: The Minnesota Heart Survey. Circulation 2001;104: Shahar E, Lee S, Kim J, et al. Hospitalized heart failure: rates and long-term mortality. J Card Fail 2004;10: Wagner S, Cohn K. Heart failure. A proposed definition and classification. Arch Intern Med 1977;137: Guggenmoos-Holzmann I, van Houwelingen HC. The (in)validity of sensitivity and specificity. Stat Med 2000;19: Torrance-Rynard VL, Walter SD. Effects of dependent errors in the assessment of diagnostic test performance. Stat Med 1997;16: Walter SD, Irwig LM. Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. J Clin Epidemiol 1988;41: Rindskopf D, Rindskopf W. The value of latent class analysis in medical diagnosis. Stat Med 1986;5: Uebersax JS, Grove WM. Latent class analysis of diagnostic agreement. Stat Med 1990;9: Hagenaars J, McCutcheon A. Applied latent class analysis. Cambridge, UK: Cambridge University Press, McCutcheon A. Latent class analysis. Newbury Park, CA: Sage Publications, Kaldor J, Clayton D. Latent class analysis in chronic disease epidemiology. Stat Med 1985;4: Vermunt JK, Magidson J. Latent GOLD 2.0 user s guide. Belmont, MA: Statistical Innovations, Inc, Harlan WR, Oberman A, Grimm R, et al. Chronic congestive heart failure in coronary artery disease: clinical criteria. Ann Intern Med 1977;86: Feinstein AR. Clinimetrics. New Haven, CT: Yale University Press, Ascherio A, Rimm EB, Giovannucci EL, et al. A prospective study of nutritional factors and hypertension among US men. Circulation 1992;86: Aldoori WH, Giovannucci EL, Rimm EB, et al. A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr 1994;60: Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population: The Rotterdam Study. Eur Heart J 2001;22: Murdoch DR, Love MP, Robb SD, et al. Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland Eur Heart J 1998;19:

10 10 Kim et al. 40. Changes in mortality from heart failure United States, MMWR Morb Mortal Wkly Rep 1998;47: Pernenkil R, Vinson JM, Shah AS, et al. Course and prognosis in patients > or ¼ 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997;79: Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000;102: Zannad F, Braincon S, Juilliere Y, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: The EPICAL Study. Epidemiologie de l Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 1999;33: Rector TS, Cohn JN. Prognosis in congestive heart failure. Annu Rev Med 1994;45: Cowie MR, Wood DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 2000;83: Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993;22:6A 13A. 47. Killip T 3rd, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967;20:

ALLHAT. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute

ALLHAT.   U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute U.S. Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute Review of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment

More information

The validity of a diagnosis of heart failure in a hospital discharge register

The validity of a diagnosis of heart failure in a hospital discharge register The European Journal of Heart Failure 7 (2005) 787 791 www.elsevier.com/locate/heafai The validity of a diagnosis of heart failure in a hospital discharge register Erik Ingelsson a, *, Johan Ärnlfv a,

More information

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease

THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS. 1. Cardiovascular Disease THE FRAMINGHAM STUDY Protocol for data set vr_soe_2009_m_0522 CRITERIA FOR EVENTS 1. Cardiovascular Disease Cardiovascular disease is considered to have developed if there was a definite manifestation

More information

Survival Associated with Two Sets of Diagnostic Criteria for Congestive Heart Failure

Survival Associated with Two Sets of Diagnostic Criteria for Congestive Heart Failure American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 160, No. 7 Printed in U.S.A. DOI: 10.1093/aje/kwh268 Survival Associated

More information

EHMRG SCORE STUDY version 6.2; date: 11Jul11 PI: Dr. Douglas Lee. Study Background

EHMRG SCORE STUDY version 6.2; date: 11Jul11 PI: Dr. Douglas Lee. Study Background EHMRG SCORE STUDY version 6.2; date: 11Jul11 PI: Dr. Douglas Lee Study Background Heart failure (HF) is a leading cause of morbidity and cardiovascular mortality. The burden of HF has increased over time

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM ID NUMBER: FORM NAME: H F A DATE: 10/01/2015 VERSION: D CONTACT YEAR NUMBER: FORM SEQUENCE NUMBER: General Instructions: The Heart Failure Hospital Record

More information

Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient

Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient Prevention of Atrial Fibrillation and Heart Failure in the Hypertensive Patient The Issue of Primary Prevention of A.Fib. (and Heart Failure) and not the Prevention of Recurrent A.Fib. after Electroconversion

More information

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept (MBBS)(SBMD) Introduction Epidemiology Pathophysiology diastolic/systolic Risk factors Signs and symptoms Classification of HF

More information

Heart failure (HF) is a complex clinical syndrome that results in the. impairment of the heart s ability to fill or to pump out blood.

Heart failure (HF) is a complex clinical syndrome that results in the. impairment of the heart s ability to fill or to pump out blood. Introduction: Heart failure (HF) is a complex clinical syndrome that results in the impairment of the heart s ability to fill or to pump out blood. As of 2013, an estimated 5.8 million people in the United

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

Diastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012

Diastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012 Diastolic Heart Failure Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012 Disclosures Have spoken for Merck, Sharpe and Dohme Sat on a physician advisory

More information

Cohort Surveillance Heart Failure Occurrences Data Dictionary

Cohort Surveillance Heart Failure Occurrences Data Dictionary Atherosclerosis Risk in Communities Study Cohort Surveillance Heart Failure s Data Dictionary September 2017 Cohort Surveillance Heart Failure s Data Dictionary : An occurrence refers to a single hospitalization,

More information

DUKECATHR Dataset Dictionary

DUKECATHR Dataset Dictionary DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of

More information

Patients With Mild Heart Failure Worsen During Withdrawal From Digoxin Therapy

Patients With Mild Heart Failure Worsen During Withdrawal From Digoxin Therapy 42 JACC Vol. 30, No. 1 Patients With Mild Heart Failure Worsen During Withdrawal From Digoxin Therapy KIRKWOOD F. ADAMS, JR., MD, FACC, MIHAI GHEORGHIADE, MD, FACC,* BARRY F. URETSKY, MD, FACC, JAMES B.

More information

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover

More information

A study of Brain Natriuretic Peptide levels in acute cardiac failure

A study of Brain Natriuretic Peptide levels in acute cardiac failure Original Research Article A study of Brain Natriuretic Peptide levels in acute cardiac failure Bhavik Prajapati 1*, Anirudh Kulkarni 2 1 Assistant Professor, Department of Medicine, SMS Multispecialty

More information

10. Definition of cardiovascular disease 10.1 Nosologic definitions Acute myocardial infarction: myocardial cell death due to prolonged ischaemia 62.

10. Definition of cardiovascular disease 10.1 Nosologic definitions Acute myocardial infarction: myocardial cell death due to prolonged ischaemia 62. 10. Definition of cardiovascular disease 10.1 Nosologic definitions Acute myocardial infarction: myocardial cell death due to prolonged ischaemia 62. Acute coronary syndrome: it is a big category which

More information

Thiazolidinedione-Associated Congestive Heart Failure and Pulmonary Edema

Thiazolidinedione-Associated Congestive Heart Failure and Pulmonary Edema Search the Journal search Advanced Search > Home Current Issue Past Issues Reprints Submissions Subscriptions Permissions About Us MAYO CLIN PROC. 2003;78:1088-1091 2003 MAYO FOUNDATION FOR MEDICAL EDUCATION

More information

QUESTION-BY-QUESTION INSTRUCTIONS FOR MMCC HEART FAILURE FINAL DIAGNOSIS FORM (HDX)

QUESTION-BY-QUESTION INSTRUCTIONS FOR MMCC HEART FAILURE FINAL DIAGNOSIS FORM (HDX) QUESTION-BY-QUESTION INSTRUCTIONS FOR MMCC HEART FAILURE FINAL DIAGNOSIS FORM (HDX) HDX, Version A, 09-10-2009 HDX QxQ An MMCC Heart Failure Diagnosis Form (HDX) is completed for each ARIC Heart Failure

More information

ORIGINAL INVESTIGATION. Profile for Estimating Risk of Heart Failure

ORIGINAL INVESTIGATION. Profile for Estimating Risk of Heart Failure ORIGINAL INVESTIGATION Profile for Estimating Risk of Heart Failure William B. Kannel, MD, MPH; Ralph B. D Agostino, PhD; Halit Silbershatz, PhD; Albert J. Belanger, MS; Peter W. F. Wilson, MD; Daniel

More information

Clinical Presentation of Heart Failure Patients Admitted in National Institute of Cardiovascular Diseases, Dhaka

Clinical Presentation of Heart Failure Patients Admitted in National Institute of Cardiovascular Diseases, Dhaka J MEDICINE 2014; 15 : 18-22 Clinical Presentation of Heart Failure Patients Admitted in National Institute of Cardiovascular Diseases, Dhaka MD. TOUFIQUR RAHMAN, 1 AAS MAJUMDER, 2 AFZALUR RAHMAN, 3 ABDUL

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF CLASSIFICATION OF HEART FAILURE Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF DISCLOSURES: NONE CLASSIFICATION C OF HEART FAILURE NYHA I IV New paradigm Stage A: Pts at high risk of developing

More information

One-year mortality among unselected outpatients with heart failure

One-year mortality among unselected outpatients with heart failure European Heart Journal (2002) 23, 1861 1866 doi:10.1053/euhj.2002.3282, available online at http://www.idealibrary.com on One-year mortality among unselected outpatients with heart failure J. Muntwyler

More information

The American Experience

The American Experience The American Experience Jay F. Piccirillo, MD, FACS, CPI Department of Otolaryngology Washington University School of Medicine St. Louis, Missouri, USA Acknowledgement Dorina Kallogjeri, MD, MPH- Senior

More information

Form 136 WHI WOMEN S HEALTH INITIATIVE HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM

Form 136 WHI WOMEN S HEALTH INITIATIVE HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM Form 136 WHI WOMEN S HEALTH INITIATIVE HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM FORM NAME: H T F DATE: 10/31/2012 VERSION: A MEMBER ID NUMBER: General Instructions: This form should be completed

More information

Definition of Congestive Heart Failure

Definition of Congestive Heart Failure Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million

More information

ACUTE HEART FAILURE in the ED. Pr. Samir Nouira Emergency Department Fattouma Bourguiba University Hospital Monastir Tunisia

ACUTE HEART FAILURE in the ED. Pr. Samir Nouira Emergency Department Fattouma Bourguiba University Hospital Monastir Tunisia ACUTE HEART FAILURE in the ED Pr. Samir Nouira Emergency Department Fattouma Bourguiba University Hospital Monastir Tunisia ACUTE HEART FAILURE 80% Acute Heart Failure Syndrome Sensitivity Specificity

More information

The right heart: the Cinderella of heart failure

The right heart: the Cinderella of heart failure The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart

More information

JHS-ARIC Cohort Surveillance Heart Failure Occurrences Data Dictionary

JHS-ARIC Cohort Surveillance Heart Failure Occurrences Data Dictionary JHS-ARIC Cohort Surveillance Heart Failure s Data Dictionary : An occurrence refers to a single hospitalization, fatal or non-fatal, with a unique ID. Table of Contents 1. Classification Variables... 3

More information

The Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease

The Prognostic Importance of Comorbidity for Mortality in Patients With Stable Coronary Artery Disease Journal of the American College of Cardiology Vol. 43, No. 4, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.10.031

More information

Online Appendix (JACC )

Online Appendix (JACC ) Beta blockers in Heart Failure Collaborative Group Online Appendix (JACC013117-0413) Heart rate, heart rhythm and prognostic effect of beta-blockers in heart failure: individual-patient data meta-analysis

More information

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart

More information

University of Massachusetts Medical School Andrew H. Coles University of Massachusetts Medical School

University of Massachusetts Medical School Andrew H. Coles University of Massachusetts Medical School University of Massachusetts Medical School escholarship@umms GSBS Dissertations and Theses Graduate School of Biomedical Sciences 8-18-2014 Long-Term Survival and Prognostic Factors in Patients with Acute

More information

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations

More information

ACUTE MYOCARDIAL INFARCTION: DIAGNOSTIC DIFFICULTIES AND OUTCOME IN ADVANCED OLD AGE

ACUTE MYOCARDIAL INFARCTION: DIAGNOSTIC DIFFICULTIES AND OUTCOME IN ADVANCED OLD AGE Age and Ageing 1987;1:239-23 J. J. DAY Research Registrar A. J. BAYS* Research Lecturer rssssffl 1^^' J. S. CHADRA Locum Consultant Geriatrician St Tydftl's Hospital, Merthyr Tydfll, Mid Glam. CF7 OSJ

More information

Dr Dinna Soon. Consultant Cardiologist, Department of Cardiology. GP symposium 2 April 2016

Dr Dinna Soon. Consultant Cardiologist, Department of Cardiology. GP symposium 2 April 2016 Dr Dinna Soon Consultant Cardiologist, Department of Cardiology GP symposium 2 April 2016 Case presentation 76 years old male, chronic smoker, hypertension, previous MI 3/7 SOB and chest tightness BP

More information

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Pinpoint & properly assign the appropriate heart failure codes Left- vs. Right-sided Left ventricular failure (LVF) may

More information

Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment

Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment ESC 2012 27Aug - 3Sep, 2012, Munich, Germany Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment Marco Metra, MD, FESC Cardiology University

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE

THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE THE IMPORTANCE OF COMORBIDITY DATA TO CANCER STATISTICS AND ROUTINE COLLECTION BY CANCER REGISTRARS COPYRIGHT NOTICE Washington University grants permission to use and reproduce the The Importance of Comorbidity

More information

Value of echocardiography in chronic dyspnea

Value of echocardiography in chronic dyspnea Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting

More information

How much atrial fibrillation causes symptoms of heart failure?

How much atrial fibrillation causes symptoms of heart failure? ORIGINAL PAPER How much atrial fibrillation causes symptoms of heart failure? M. Guglin, R. Chen Linked Comment: Lip. Int J Clin Pract 2014; 68: 408 9. SUMMARY Introduction: Patients with atrial fibrillation

More information

IT HAS been estimated that congestive

IT HAS been estimated that congestive ORIGINAL INVESTIGATION Congestive Heart Failure in the Community Trends in Incidence and Survival in a 1-Year Period Michele Senni, MD; Christophe M. Tribouilloy, MD, PhD; Richard J. Rodeheffer, MD; Steven

More information

Contemporary Clinical Pearls in Physical Diagnosis: A Multi-Media Look at Actual Findings & Sounds, Hemodynamics, and What the Literature Has to Say

Contemporary Clinical Pearls in Physical Diagnosis: A Multi-Media Look at Actual Findings & Sounds, Hemodynamics, and What the Literature Has to Say Contemporary Clinical Pearls in Physical Diagnosis: A Multi-Media Look at Actual Findings & Sounds, Hemodynamics, and What the Literature Has to Say James C. Fang, MD Harrington Heart and Vascular Institute

More information

Heart Failure Clinician Guide JANUARY 2016

Heart Failure Clinician Guide JANUARY 2016 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.

More information

Listing Form: Heart or Cardiovascular Impairments. Medical Provider:

Listing Form: Heart or Cardiovascular Impairments. Medical Provider: Listing Form: Heart or Cardiovascular Impairments Medical Provider: Printed Name Signature Patient Name: Patient DOB: Patient SS#: Date: Dear Provider: Please indicate whether your patient s condition

More information

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts

More information

Results from RE-LY and RELY-ABLE

Results from RE-LY and RELY-ABLE Results from RE-LY and RELY-ABLE Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in longterm stroke prevention EXECUTIVE SUMMARY Dabigatran etexilate (Pradaxa ) has shown a consistent

More information

Saudi Journal of Medicine (SJM)

Saudi Journal of Medicine (SJM) Saudi Journal of Medicine (SJM) Scholars Middle East Publishers Dubai, United Arab Emirates Website: http://scholarsmepub.com/ ISSN 2518-3389 (Print) ISSN 2518-3397 (Online) A Clinical Study of Chronic

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life

More information

ARIC. HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM with SUPPLEMENTAL INFORMATION

ARIC. HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM with SUPPLEMENTAL INFORMATION ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM with SUPPLEMENTAL INFORMATION ID NUMBER: FORM NAME: H F S DATE: 06/28/2012 VERSION: B Note: This form will only be done on a subset of participants.

More information

ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial

ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial 1 ALLHAT Role of Diuretics in the Prevention of Heart Failure - The Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial Davis BR, Piller LB, Cutler JA, et al. Circulation 2006.113:2201-2210.

More information

Clinical Policy Title: Cardiac rehabilitation

Clinical Policy Title: Cardiac rehabilitation Clinical Policy Title: Cardiac rehabilitation Clinical Policy Number: 04.02.02 Effective Date: September 1, 2013 Initial Review Date: February 19, 2013 Most Recent Review Date: February 6, 2018 Next Review

More information

Heart Failure with Johnny Crash: LEFT VENTRICULAR EJECTION FRACTION (LVEF) SYMPTOMATOLOGY: Assess VENTRICULAR DYSFUNCTION HEART FAILURE:

Heart Failure with Johnny Crash: LEFT VENTRICULAR EJECTION FRACTION (LVEF) SYMPTOMATOLOGY: Assess VENTRICULAR DYSFUNCTION HEART FAILURE: Heart Failure with Johnny Crash: Joan E. King, PhD, ACNP-BC, ANP-BC Melissa Smith, DNP, ANP-BC Vanderbilt University School of Nursing HEART FAILURE: Heart Failure (HF): a complex clinical syndrome resulting

More information

CAPTIVATE SUMMARY CLINICAL SUMMARY. CAPTure Information Via Automatic Threshold Evaluation

CAPTIVATE SUMMARY CLINICAL SUMMARY. CAPTure Information Via Automatic Threshold Evaluation CLINICAL SUMMARY CAPTIVATE SUMMARY CAPTure Information Via Automatic Threshold Evaluation CAUTION: Federal law restricts this device to sale by or on the order of a physician trained or experienced in

More information

EAJEM-22932: Araştırma Makalesi. Acute onset of breathlessness in emergency department. Page 1 / 15. JournalAgent powered by LookUs

EAJEM-22932: Araştırma Makalesi. Acute onset of breathlessness in emergency department. Page 1 / 15. JournalAgent powered by LookUs EAJEM-22932: Araştırma Makalesi Acute onset of breathlessness in emergency department 5 10 15 20 25 AIM: Acute onset of breathlessness is one of the most common potentially life threatening situations

More information

Incidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction

Incidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction Heart Failure Diagnosis According to the Working Group in Heart Failure, CHF is a syndrome where the diagnosis has the following essential components: A combination of: Symptoms, typically breathlessness

More information

Trials Enrolled subjects Findings Fox et al. 2014, SIGNIFY 1

Trials Enrolled subjects Findings Fox et al. 2014, SIGNIFY 1 Appendix 5 (as supplied by the authors): Published trials on the effect of ivabradine on outcomes including mortality in patients with different cardiovascular diseases Trials Enrolled subjects Findings

More information

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease

Low fractional diastolic pressure in the ascending aorta increased the risk of coronary heart disease (2002) 16, 837 841 & 2002 Nature Publishing Group All rights reserved 0950-9240/02 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Low fractional diastolic pressure in the ascending aorta increased the risk

More information

Metoprolol CR/XL in Female Patients With Heart Failure

Metoprolol CR/XL in Female Patients With Heart Failure Metoprolol CR/XL in Female Patients With Heart Failure Analysis of the Experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF) Jalal K. Ghali, MD; Ileana L.

More information

Heart Failure Clinician Guide JANUARY 2018

Heart Failure Clinician Guide JANUARY 2018 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.

More information

February 25, WHI Heart Failure Data Summary. A. Original WHI outcome (referred to as CHF)

February 25, WHI Heart Failure Data Summary. A. Original WHI outcome (referred to as CHF) February 25, 2014 WHI Heart Failure Data Summary A. Original WHI outcome (referred to as CHF) Process: Sample: Collected and centrally adjudicated for HT participants and locally adjudicated on all non-ht

More information

Managing Hypertension In Heart Failure Patients In A Teaching Hospital In Ghana

Managing Hypertension In Heart Failure Patients In A Teaching Hospital In Ghana ISPUB.COM The Internet Journal of Cardiovascular Research Volume 7 Number 1 Managing Hypertension In Heart Failure Patients In A Teaching Hospital In Ghana A Charles, M v, O Isaac Citation A Charles, M

More information

The ACC 50 th Annual Scientific Session

The ACC 50 th Annual Scientific Session Special Report The ACC 50 th Annual Scientific Session Part One From March 18 to 21, 2001, physicians from around the world gathered to learn, to teach and to discuss at the American College of Cardiology

More information

NT-proBNP: Evidence-based application in primary care

NT-proBNP: Evidence-based application in primary care NT-proBNP: Evidence-based application in primary care Associate Professor Rob Doughty The University of Auckland, Auckland City Hospital, Auckland Heart Group NT-proBNP: Evidence in Primary Care The problem

More information

The Counter HF Clinical Study for Heart Failure

The Counter HF Clinical Study for Heart Failure The Counter HF Clinical Study for Heart Failure CAUTION: C-Pulse is an investigational device. It is limited by Federal (or United States) Law to investigational use only. 13-111-B Agenda Heart Failure

More information

THE USE OF LATENT CLASS ANALYSIS IN MEDICAL DIAGNOSIS. David Rindskopf Educational Psychology, CUNY Graduate Center, New York, NY 10016

THE USE OF LATENT CLASS ANALYSIS IN MEDICAL DIAGNOSIS. David Rindskopf Educational Psychology, CUNY Graduate Center, New York, NY 10016 THE USE OF LATENT CLASS ANALYSIS IN MEDICAL DIAGNOSIS David Rindskopf Educational Psychology, CUNY Graduate Center, New York, NY 10016 KEY WORDS: Missing Data, Categorical Data, Logistic Regression, Measurement

More information

Journal of the American College of Cardiology Vol. 35, No. 3, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 3, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 3, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00608-7 The Prognostic

More information

Catheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?

Catheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF? : Another Option for AF Atrial fibrillation (AF) is a highly common cardiac arrhythmia and a major risk factor for stroke. In this article, Dr. Khan and Dr. Skanes detail how catheter ablation significantly

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 27 May 2009

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 27 May 2009 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 27 May 2009 CARDENSIEL 1.25 mg, film-coated tablet B/30 (CIP code: 352 968-1) CARDENSIEL 2.5 mg, film-coated tablet

More information

Standard emergency department care vs. admission to an observation unit for low-risk chest pain patients. A two-phase prospective cohort study

Standard emergency department care vs. admission to an observation unit for low-risk chest pain patients. A two-phase prospective cohort study Standard emergency department care vs. admission to an observation unit for low-risk chest pain patients A. STUDY PURPOSE AND RATIONALE Rationale: A two-phase prospective cohort study IRB Proposal Sara

More information

Lnformation Coverage Guidance

Lnformation Coverage Guidance Lnformation Coverage Guidance Coverage Indications, Limitations, and/or Medical Necessity Abstract: B-type natriuretic peptide (BNP) is a cardiac neurohormone produced mainly in the left ventricle. It

More information

POOR LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION AMONG PATIENTS ON LONG-TERM DIALYSIS

POOR LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION AMONG PATIENTS ON LONG-TERM DIALYSIS POOR LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL INFARCTION AMONG PATIENTS ON LONG-TERM DIALYSIS CHARLES A. HERZOG, M.D., JENNIE Z. MA, PH.D., AND ALLAN J. COLLINS, M.D. ABSTRACT Background Cardiovascular

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright 2002 by the Massachusetts Medical Society VOLUME 347 A UGUST 1, 2002 NUMBER 5 OBESITY AND THE RISK OF HEART FAILURE SATISH KENCHAIAH, M.D., JANE C. EVANS,

More information

National public health campaigns have attempted

National public health campaigns have attempted WINTER 2005 PREVENTIVE CARDIOLOGY 11 CLINICAL STUDY Knowledge of Cholesterol Levels and Targets in Patients With Coronary Artery Disease Susan Cheng, MD; 1,2 Judith H. Lichtman, MPH, PhD; 3 Joan M. Amatruda,

More information

COPD as a comorbidity of heart failure in elderly patients

COPD as a comorbidity of heart failure in elderly patients COPD as a comorbidity of heart failure in elderly patients Professor Mitja Lainscak, MD, PhD, FESC, FHFA Departments of Cardiology and Research&Education, General Hospital Celje Faculty of Medicine, University

More information

Mode of admission and its effect on quality indicators in Belgian STEMI patients

Mode of admission and its effect on quality indicators in Belgian STEMI patients 2015 Mode of admission and its effect on quality indicators in Belgian STEMI patients Prof dr M Claeys National Coordinator STEMI registry 29-6-2015 Background The current guidelines for the management

More information

HEART failure with preserved left ventricular systolic

HEART failure with preserved left ventricular systolic Journal of Gerontology: MEDICAL SCIENCES 2005, Vol. 60A, No. 10, 1339 1344 Copyright 2005 by The Gerontological Society of America Association of Diastolic Dysfunction and Outcomes in Ambulatory Older

More information

CASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG

CASE DISCUSSION. Dr JAYASREE VEERABOINA 2nd yr PG MS OBG CASE DISCUSSION Dr JAYASREE VEERABOINA 2nd yr PG MS OBG Normal Cardiovascular changes in Pregnancy CARDIAC OUTPUT 5 th wk -- starts 12 wks -- 30-35% 30-32 wks -- 40% During labour -- 50% After delivery

More information

Rehospitalization Prognostic Factors in Patients with Heart Failure: a Prospective Follow-up Study

Rehospitalization Prognostic Factors in Patients with Heart Failure: a Prospective Follow-up Study ARC Journal of Cardiology Volume2, Issue 2, 2016, PP 13-18 ISSN No. (Online) 2455-5991 http://dx.doi.org/10.20431/2455-5991.0202002 www.arcjournals.org Rehospitalization Prognostic Factors in Patients

More information

Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Normal Cardiac Anatomy

Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Normal Cardiac Anatomy Mosby,, an affiliate of Elsevier Normal Cardiac Anatomy Impaired cardiac pumping Results in vasoconstriction & fluid retention Characterized by ventricular dysfunction, reduced exercise tolerance, diminished

More information

Drug prescriptions (Pharm) Exposure (36/48 months)

Drug prescriptions (Pharm) Exposure (36/48 months) ANNEX SECTION PART A - Study design: Figure 1 overview of the study design Drug prescriptions (Pharm) 2006-2010 Exposure (36/48 months) flexible time windows (e.g. 90 days) time index date (hospital discharge)

More information

Pathophysiology: Heart Failure

Pathophysiology: Heart Failure Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Medicine Outline Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology Heart Failure: Definitions

More information

Heart failure: what should be changed? Prof. Gerasimos Filippatos Attikon University Hospital

Heart failure: what should be changed? Prof. Gerasimos Filippatos Attikon University Hospital Heart failure: what should be changed? Prof. Gerasimos Filippatos Attikon University Hospital Disclosures Chair or Committee Member of trials or registries sponsored by Novartis, Bayer, Cardiorentis, Servier

More information

Dr. A. Manjula, No. 7, Doctors Quarters, JLB Road, Next to Shree Guru Residency, Mysore, Karnataka, INDIA.

Dr. A. Manjula, No. 7, Doctors Quarters, JLB Road, Next to Shree Guru Residency, Mysore, Karnataka, INDIA. Original Article In hypertensive patients measurement of left ventricular mass index by echocardiography and its correlation with current electrocardiographic criteria for the diagnosis of left ventricular

More information

H eart failure is a common and disabling condition

H eart failure is a common and disabling condition 755 CARDIOVASCULAR MEDICINE Management of chronic heart failure in the community: role of a hospital based open access heart failure service S Shah, M K Davies, D Cartwright, P Nightingale... See end of

More information

Heart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital

Heart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital Heart Failure and COPD: Common Partners, Common Problems Nat Hawkins Liverpool Heart and Chest Hospital Disclosures: No conflicts of interest Common partners, common problems COPD in HF common partners

More information

Practical Points in Cardiorenal Syndrome

Practical Points in Cardiorenal Syndrome Practical Points in Cardiorenal Syndrome Vichai Senthong, MD. Cardiovascular Unit, Faculty of Medicine Khon Kaen university HFCT Annual Scientific Meeting June 16, 2017, Eastin Grand Sathorn Hotel, Bangkok

More information

Critical Review Form Therapy Objectives: Methods:

Critical Review Form Therapy Objectives: Methods: Critical Review Form Therapy Clinical Trial Comparing Primary Coronary Angioplasty with Tissue-Plasminogen Activator for Acute Myocardial Infarction (GUSTO-IIb), NEJM 1997; 336: 1621-1628 Objectives: To

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/188/20915 holds various files of this Leiden University dissertation. Author: Flinterman, Linda Elisabeth Title: Risk factors for a first and recurrent venous

More information

LCD L B-type Natriuretic Peptide (BNP) Assays

LCD L B-type Natriuretic Peptide (BNP) Assays LCD L30559 - B-type Natriuretic Peptide (BNP) Assays Contractor Information Contractor Name: Novitas Solutions, Inc. Contractor Number(s): 12501, 12502, 12101, 12102, 12201, 12202, 12301, 12302, 12401,

More information

THE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION

THE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION THE PROPER APPROACH TO DIAGNOSING HEART FAILURE WITH PRESERVED EJECTION FRACTION James C. Fang, MD, FACC Professor and Chief Cardiovascular Division University of Utah School of Medicine Disclosures Data

More information

Topic Page: congestive heart failure

Topic Page: congestive heart failure Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation

More information

Influence of diabetes on the survival of patients hospitalized with heart failure: A 12-year study

Influence of diabetes on the survival of patients hospitalized with heart failure: A 12-year study The European Journal of Heart Failure 7 (005) 59 www.elsevier.com/locate/heafai Influence of diabetes on the survival of patients hospitalized with heart failure: A 1-year study Abstract Alfonso Varela-Roman,

More information

Clinical research and epidemiological studies of heart failure. Original Article

Clinical research and epidemiological studies of heart failure. Original Article Original Article Classification of Acute Decompensated Heart Failure An Automated Algorithm Compared With a Physician Reviewer Panel: The Atherosclerosis Risk in Communities Study Laura R. Loehr, MD, PhD*;

More information

Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore

Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore Journal Club 13 Febbraio 2008 Fattori condizionanti la sopravvivenza nel paziente con scompenso di cuore Intissar Sleiman Prevalence of heart failure by sex and age (NHANES:1999-2004) Circulation 2007

More information

RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION

RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION RACIAL DIFFERENCES IN THE OUTCOME OF LEFT VENTRICULAR DYSFUNCTION DANIEL L. DRIES, M.D., M.P.H., DEREK V. EXNER, M.D., BERNARD J. GERSH,

More information

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the

More information

Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema

Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema A.D. Margulescu 1,2, R.C. Sisu 1,2, M. Florescu 2,

More information